tiprankstipranks
RBC Capital upgrades Regenxbio to Outperform, sees positive risk-reward
PremiumThe FlyRBC Capital upgrades Regenxbio to Outperform, sees positive risk-reward
2M ago
Regenxbio upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe Fly
Regenxbio upgraded to Outperform from Sector Perform at RBC Capital
2M ago
Regenxbio price target raised to $55 from $45 at Barclays
PremiumThe Fly
Regenxbio price target raised to $55 from $45 at Barclays
2M ago
Regenxbio upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyRegenxbio upgraded to Outperform from Market Perform at Leerink
2M ago
Regenxbio price target raised to $39 from $34 at Baird
PremiumThe Fly
Regenxbio price target raised to $39 from $34 at Baird
2M ago
Regenxbio’s RGX-202 shows initial efficacy in Duchenne
PremiumThe Fly
Regenxbio’s RGX-202 shows initial efficacy in Duchenne
2M ago
Regenxbio resumed with an Outperform at Raymond James
PremiumThe FlyRegenxbio resumed with an Outperform at Raymond James
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Regenxbio to hold a conference call
PremiumThe Fly
Regenxbio to hold a conference call
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100